A high-resolution screening (HRS) technology is described, which couples 2 parallel enzyme affinity detection (EAD) systems for substrates and inhibitors of rat cytosolic glutathione-S-transferases (cGSTs) and purified human GST P1 to gradient reversed-phase high-performance liquid chromatography (HPLC). The cGSTs and GST P1 EAD systems were optimized and validated first in flow injection analysis (FIA) mode, and optimized values were subsequently used for HPLC mode. The IC 50 values of 8 ligands thus obtained online agreed well with the IC 50 values obtained with microplate reader-based assays. For ethacrynic acid, an IC 50 value of 1.8 ± 0.4 µM was obtained with the cGSTs EAD system in FIA mode and 0.8 ± 0.6 µM in HPLC mode. For ethacrynic acid with the GST P1 EAD system, IC 50 values of 6.0 ± 2.9 and 3.6 ± 2.8 µM were obtained in FIA and HPLC modes, respectively. An HRS GST EAD system, consisting of both the cGSTs and the GST P1 EAD system in HPLC mode in parallel, was able to separate complex mixtures of compounds and to determine online their individual affinity for cGSTs and GST P1. Finally, a small library of GST inhibitors, synthesized by reaction of several electrophiles with glutathione (GSH), was successfully screened with the newly developed parallel HRS GST EAD system. It is concluded that the present online gradient HPLC-based HRS screening technology offers new perspectives for sensitive and simultaneous screening of general cGSTs and specific GST P1 inhibitors in mixtures. (Journal of Biomolecular Screening 2007:396-405) 
INTRODUCTION
T HE ELIMINATION OF HYDROPHOBIC XENOBIOTICS from the body often depends on their biotransformation to watersoluble compounds. Gluthatione-S-transferases (GSTs) constitute an important class of predominantly cytosolic enzymes that play a role in the biotransformation of a wide variety of electrophilic compounds by catalyzing their conjugation to glutathione (GSH). 1 Substrates for cytosolic GSTs range from naturally occurring xenobiotics, anticancer drugs, 2 electrophilic reactive intermediates, 3 and endogenous compounds, such as prostaglandines 1 and lipid peroxidation products, 4 that are metabolized to GSH conjugates. 5 GSTs have also been suggested to be involved in anticancer drug resistance. 6 The observation that GST inhibitors, such as ethacrynic acid, sensitize cancer cells to anticancer drugs, such as melphalan, 7 has compelled investigators to the development of inhibitors as adjuvants for chemotherapy with alkylating agents. 8, 9 However, in such a strategy using broad-range inhibitors such as ethacrynic acid, one must take into consideration possible cytotoxic effects in normal cells due to diminished GST-mediated defense as well. Selective GST inhibitors are expected to cause fewer problems in this regard. 8, 10 The expression levels of the different classes of GSTs differ significantly in different cell types and organs. Increased expression of certain classes of GSTs 11, 12 facilitates the excretion of toxicants through GSH conjugation. A well-known example is the overexpression of GST P1 in multidrug-resistant tumor cells. 13 Although this type of overexpression might implicate resistance of cells to chemotherapy, this relation is not yet fully elucidated, and overexpression might also be a cellular stress response. These observations indicate GST P1 inhibitors to be potential drugs coassisting cytostatics. 10, [14] [15] [16] [17] [18] [19] Due to the fact that mixtures of GST inhibitors display complex inhibitory responses in the usual GST inhibition assays, little can be concluded about the specificity of individual inhibitors in such mixtures. Selectivity and affinity of individual inhibitors in mixtures therefore have to be evaluated after cumbersome, mainly high-performance liquid chromatography (HPLC)-based dereplication processes. 20 The ability to detect bioaffinities in an HPLC effluent stream may eliminate much of the time and labor taken in dereplication strategies. Several of such online postcolumn HPLC-based biochemical detection systems, referred to as high-resolution screening (HRS) systems, have been developed during the past decade. HRS-based bioaffinity assays have been based on enzymes such as angiotensin-converting enzymes 21 and cytochromes P450, 22 on soluble receptors such as the estrogen receptor, 23 and on antibodies. 24 Here we describe the development of an HRS technology comprising gradient HPLC coupled online with 2 parallel enzyme affinity detection (EAD) systems containing GSTs. One EAD system monitors the HPLC eluent for ligands of cytosolic GSTs (cGSTs) and the other system for ligands of GST P1. The parallel placed EAD systems are operated by continuous mixing of cGSTs or GST P1 with substrate mono-chlorobimane, cofactor glutathione (GSH), and carrier solution, in separate reaction coils (one for the cGSTs and one for GST P1). In the reaction coils, mono-chlorobimane is converted into the fluorescent product glutathione-bimane (GSH-bimane). 25 Ligands eluting from the upstream HPLC system compete with mono-chlorobimane for the active site of the GSTs, thus causing temporary decreases in the formation of fluorescent GSH-bimane product, resulting in temporary decreases in the baseline fluorescence signal ("negative peaks"). The cGSTs and the GST P1 EAD systems were first evaluated and optimized individually with pure GST ligands in a flow injection analysis (FIA) mode and subsequently analyzed with the total HRS GST EAD system. Specific GST P1 inhibitors in mixtures also containing nonspecific GST inhibitors were easily identified with the total HRS GST EAD system. Finally, a library of GSH derivatives, assembled by reaction of electrophilic compounds with GSH, was screened online for potential cGSTs and GST P1 inhibitors.
MATERIALS AND METHODS

Materials
Mono-chlorobimane, Tween 20, Tween 80, saponin (from Quillaja Bark), polyethylene glycol 6000 (PEG 6000), polyethylene glycol 3350 (PEG 3350), reduced glutathione (GSH), phenacetin, ethacrynic acid, crotonaldehyde, chloro-2,4-dinitrobenzene (CDNB), and curcumine were purchased from Sigma (Zwijndrecht, the Netherlands). 2-Chloro-5nitropyridine and 2-chloro-5-nitrobenzaldehyde came from Fluka (Zwijndrecht, the Netherlands). Acrolein was obtained from Acros (Den Bosch, the Netherlands). 4-Chloro-3-nitrobenzoic acid butyl ester 26 and n-butyl-2-chloro-5-nitrobenzoate 27 were synthesized as described by Van der Aar et al. 27 Sodium cholate, cinnamaldehyde, 4-chloro-3-nitrobenzaldehyde, and 2-chloro-5-nitrobenzonitrile were obtained from Aldrich (Zwijndrecht, the Netherlands). Enzyme-linked immunosorbent assay (ELISA) blocking reagent was purchased from Roche (Mannheim, Germany), and bovine serum albumin (BSA) was from Life Technologies (Paisley, UK). Methanol (MeOH), isopropanol (IPA), acetic acid, glycol, and acetonitrile (MeCN) were purchased from Baker (Deventer, the Netherlands) and were of HPLC reagent grade.
The 4 GSH analogs-DB1, 2, 3, and 4-were a kind gift from Dr. D. Burg (Division of Toxicology, LACDR-Leiden, the Netherlands): DB1: 5-(4-amino-4-carboxy-butyryl-amino)-5-(1methyl-hexylcarbamoyl)-pentanoic acid; DB2: 2-Amino-4-
GST enzymes. Rat liver cytosol was prepared from untreated rats as described by Rooseboom et al. 28 The GST concentration in the cytosolic fraction was 34 mg/mL. Purified human GST P1 (5.3 mg/mL potassium phosphate buffer, pH 7.3), isolated from Escherichia coli expressing high concentrations of GST P1, was a kind gift from Prof. M. Lo Bello (Department of Biology, University of Rome, Italy). 29
Instrumentation
The cGSTs and GST P1 EAD systems consisted of identical instrumentation ( Fig. 1 ). Per EAD system, two 100-mL superloops, made in house, were used. Superloop A (SL-A) contained enzyme (rat liver cGSTs or purified human GST P1), and superloop B (SL-B) contained cofactor (GSH) and substrate (monochlorobimane). For each EAD system, 2 Knauer K-500 HPLC pumps (Berlin, Germany) were used to control the superloops and one for delivery of the injected samples in FIA mode. The superloops were kept on ice. Proper operation of the pumps at low flow rates was achieved in a similar way as described by Kool et al. 22 When operated in HPLC mode, Knauer K-500 HPLC pumps controlled the HPLC and the counteracting gradient flows. In this case, an Agilent 1100 series UV detector (220 nm) monitored the HPLC eluent parallel to one of the GST EAD systems that was used for optimization or parallel to the total HRS GST EAD system. Sample injections were performed with a Gilson 234 autoinjector (Villiers-le-Bel, France) equipped with a Rheodyne (Bensheim, Germany) 6-port injection valve (injection loop, 50 µL in FIA mode or 500 µL in HPLC mode). Agilent 1100 (Waldbronn, Germany) series fluorescence detectors (λ ex 390 nm; λ em 465 nm) were used for monitoring of the fluorescence. The temperature of the reaction coils was controlled by a Shimadzu
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CTO-10AC column oven (Duisburg, Germany). During optimization, the carrier solution was water (100 µL/min). Samples were injected in the carrier solution prior to mixing with a buffer solution containing the enzyme (100 µL/min) and the cofactor/ substrate solution (100 µL/min). Knitted PEEK reaction coils (internal volumes of 75 µL [cGSTs] and 500 µL [GST P1]) were used for the online enzymatic reactions. All hardware was integrated in 1 system by Kiadis B.V. and was controlled by software developed by Kiadis B.V. (Groningen, the Netherlands).
GST enzyme affinity detection in FIA mode
In FIA mode, both EAD systems are operated by continuous mixing of GST enzymes (cGSTs or GST P1 in SL-1), substrate (mono-chlorobimane; in SL-2), and glutathione (GSH; in SL-2) with a carrier solution instead of the effluent of a gradient HPLC system ( Fig. 1) . After mixing of the various solutions in a knitted reaction coil, the substrate mono-chlorobimane is converted into the highly fluorescent GSH conjugate GSHbimane. 25 Eluting ligands (i.e., both inhibitors and substrates) that compete with mono-chlorobimane for the active site of the GSTs cause a (temporarily) decreased production of GSHbimane, a process monitored by fluorescence detection.
GST enzyme affinity detection coupled online to HPLC
For operation of the cGSTs and GST P1 EAD systems in HPLC mode ( Fig. 1) , 2 pumps were used to control the HPLC gradient. After the HPLC column, 2 pumps compensated for the increasing concentrations of organic modifier by applying a counteracting gradient before delivery of the eluent to the GST EAD systems. HPLC separations were performed using a Phenomenex (Torrance, CA) 30 × 2-mm i.d. stainless steel column (Luna 3µ C18(2)) with a 10 × 2-mm i.d. C18 Luna precolumn. With the total HRS GST EAD system, the eluent of the HPLC was connected to a 3-way splitter and split at a 1:2:7 ratio. The 1st fraction was directed to the GST P1 EAD system, the 2nd fraction to the cGSTs EAD system, and the remaining fraction to the UV detector. For HPLC analysis, test compounds were dissolved in 40% (v/v) MeOH in water. Compounds on the HPLC column were eluted as follows: a flow rate of 200 µL/min with H 2 O-MeOH (95:5) for 1 min was followed by a gradient of 10 min to H 2 O-MeOH (5:95), except for the separation of the compound library reacted with GSH, in which a gradient of 20 min was used. Then a 25-min postgradient isocratic flow with H 2 O-MeOH (5:95) was used before equilibration back to starting conditions in 5 min. To maintain a constant concentration of organic modifier in the HRS GST EAD system, a decreasing concentration gradient of organic modifier was mixed with the eluent from the HPLC column prior to the flow splitter. This gradient was as follows: 2 min at H 2 
Microplate reader assays for GST affinity
Microplate reader assays were used for optimization of the GST EAD systems in FIA and HLPC mode. The fluorescence of the GSH-bimane conjugate was measured at excitation and emission wavelengths of 390 nm and 465 nm, respectively, on a Victor 2 1420 multilabel counter (Wallac, Turku, Finland). Different concentrations of cGSTs or GST P1, GSH, and monochlorobimane were tested. Because blocking reagents and detergents may improve the resolution of the online EAD systems 22 and because organic modifiers are necessary for the gradient HPLC system, all of these parameters were varied for both cGSTs and for GST P1. The experiments were carried out at 37 °C with well volumes of 150 µL potassium phosphate buffer (100 mM; pH 6.5). The enzymatic reactions were started by the addition of 50 µL of GSH (30 mM). All measurements were done in quadruplicate. The initial linear increase in fluorescence upon reaction of mono-chlorobimane with GSH was a measure for the enzyme activity. The effect of varying GSH concentration was investigated for cGSTs and GST P1 at concentrations of 17 and system. After high-performance liquid chromatography (HPLC), the makeup pumps produce a counteracting gradient, resulting in a constant GST EAD-compatible organic modifier concentration. The eluent is then split 1:2:7 to the GST P1 EAD system, the cGSTs EAD system, and the UV detector, respectively. Eluting ligands cause a temporary inhibition of the formation of glutathione (GSH) bimane, which is monitored with a fluorescence detector (FLD). When operated in flow injection analysis (FIA) mode (not shown in this figure), the HPLC system, including the flow split, is replaced by only a carrier solution. Ligands are injected in the carrier solution with an autosampler (AS) and transported directly to a single GST EAD system. 5 µg protein/mL, respectively, and a mono-chlorobimane concentration of 50 µM. GSH concentrations tested were 0, 0.4, 1, 2, 4, 7, 14, and 27 mM. Enzyme concentrations of 0.002 to 300 µg protein/mL cGSTs or GST Pi were examined. For monochlorobimane, concentrations of 5 nM to 100 µM were investigated. The effect of organic modifiers, blocking reagents, and detergents was tested under the following conditions: 14 µg protein/L cGSTs or 6 µg protein/mL GST Pi, a mono-chlorobimane concentration of 22 µM for cGSTs or 88 µM for GST Pi, and a GSH concentration of 7 mM. The organic modifiers MeOH, MeCN, and IPA were tested at final concentrations of 25%, 12.5%, 6.3%, 3.1%, 1.6%, 0.8%, 0.4%, and 0% (v/v). The blocking reagents PEG3350, PEG6000, ELISA, BB, and BSA were tested at final concentrations of 120, 60, 30, 15, 7, 3, and 1 mg/mL, respectively. The detergents Tween 20, Tween 80, sodium cholate, and saponin were tested at final concentrations of 4, 2, 1, 0.5, 0.3, 0.1, and 0.05 mg/mL, respectively. The optimized parameters were finally used for both GST EAD systems.
Synthesis of a library of GST inhibitors
A mixture of acrolein, cinnamaldehyde, crotonaldehyde, and ethacrynic acid (at a concentration of 1000 µM) was reacted for 2 h with GSH (10 mM) in Tris buffer (0.3 M; pH 9). The resulting GSH conjugate library was directly injected in the GST EAD systems in gradient HPLC mode.
RESULTS
The development and validation of a parallel EAD system consisting of cGSTs and GST P1 were the primary goals of this study. Figure 1 shows the final HRS configuration with the parallel GST EAD system coupled online to gradient HPLC (HRS GST EAD system). The experimental reaction conditions of the cGSTs and GST P1 EAD systems were first optimized with microplate reader-based assays. Then, both GST EAD systems were validated in FIA and HPLC modes, and finally the 2 GST EAD systems were coupled in parallel and online to gradient HPLC.
Optimization of GST EAD conditions in microplate reader format
Taking into account that the cofactor GSH can be rate limiting in the enzymatic conjugation of GSH to mono-chlorobimane, the minimal GSH concentration to obtain V max of the reactions was determined first. This concentration was found to be 7 mM for both cGSTs and for GST P1. The optimal concentrations of substrate and enzyme were determined subsequently. The optimal enzyme concentrations were 6 µg protein/mL for cGSTs and 14 µg protein/mL for GST P1. These values were a compromise between fluorescence signal-to-noise (S/N) ratios obtained at these concentrations, the amount of enzyme used for screening and clogging of the detector cell at high enzyme concentrations. The mono-chlorobimane substrate concentration showed nice Michaelis-Menten kinetics both for cGSTs and for GST P1. The apparent K m values found for the cGSTs (K m = 22 µM) and GST P1 (K m = 88 µM) were taken as optimal concentrations for the online GST EAD systems. GSTs and lipophilic compounds may in principle adsorb to the reaction coils, thus resulting in peak broadening. To reduce this type of adsorption, the effect of blocking reagents, detergents, and organic modifiers on the enzyme activity of the cGSTs and GST P1 was tested. All blocking reagents tested (i.e., PEG3350 and PEG6000, ELISA blocking reagent, and BSA) showed a less than 5% decrease in enzyme activity up to 6 mg/mL. From the detergents tested at concentrations of 100 to 200 mg/L, sodium cholate and saponin decreased the enzymatic GST activity for more than 50%. Tween 20 and Tween 80 gave better results in terms of remaining enzyme activity. At 200 to 400 mg/L, a less than 5% decrease in enzyme activity was observed for both cGSTs and GST P1. Subsequently, the organic modifiers methanol (MeOH), acetonitrile (MeCN), and isopropylalcohol (IPA) were tested. Increasing organic modifier concentrations initially led to slightly increased fluorescent signals, with an optimum at 0.5% for all organic modifiers tested. Higher concentrations of the organic modifiers decrease the enzyme activity. Organic modifier concentrations of 10% and 4% MeOH (v/v) in the reaction coil, respectively, resulted in about 15% to 20% loss in cGSTs and GST P1 activity. For IPA and MeCN, about the same percentages were found.
Optimized conditions. The optimized conditions for the online GST EAD systems, derived from the above-mentioned optimization process, were as follows: for cGSTs, superloop A contained 18 µg protein/mL cGSTs and 0.5 mg/mL PEG6000 in 100 mM potassium phosphate buffer at pH 6.5, and superloop B contained 66 µM monochlorobimane, 0.5 mg/mL PEG6000, and 21 mM GSH in 100 mM potassium phosphate buffer at pH 6.5. For GST P1, superloop A contained 42 µg protein/mL GST P1 and 0.5 mg/mL PEG6000 in 100 mM potassium phosphate buffer at pH 6.5, and superloop B contained 264 µM mono-chlorobimane, 0.5 mg/mL PEG6000, and 21 mM GSH in 100 mM potassium phosphate buffer at pH 6.5. The H 2 O and MeOH of the counteracting postcolumn gradient both contained 500 mg/L Tween 20.
The GST EAD systems in FIA mode
A basic property of both GST EAD systems is the continuous mixing of the enzymes (GSTs), nonfluorescent substrate (mono-chlorobimane), and eluent from a carrier flow in the reaction coils (Fig. 1) . In the reaction coils, a continuous formation of GSH-bimane conjugate 25 takes place, which is measured by fluorescence detection at the end of the reaction coil. When substrates or inhibitors of GSTs elute from the carrier solution (in FIA mode) or from a HPLC column (in HPLC mode), they cause a temporary decrease in the formation of the fluorescent GSH-bimane conjugate. Both the cGSTs and the GST P1 EAD system were first tested by cooling the reaction coils to 0 °C. A reduced GST enzyme activity resulted in a decreased GSH-bimane conjugate formation and hence a lower baseline. After equilibration of the reaction coils to 37 °C, the baseline levels rose as a result of increased product formation due to increased enzyme activities. Injection of the inhibitor ethacrynic acid temporarily inhibited both enzyme activities, as can be seen from the negative peaks on the baseline (Fig. 2) . Blank injections showed no significant changes in the baseline levels. Injections of ethacrynic acid with the reaction coils at 0°C gave no peaks at the baseline signal, thus proving that the fluorescence signals were GST enzyme and ethacrynic acid dependent and not caused by fluorescence quenching.
Variability
Interday and intraday variability of the cGSTs and the GST P1 EAD assays in FIA mode were determined as follows: intraday variability was determined by injecting ethacrynic acid (6 µM) in triplicate at 4-h time intervals, under optimized conditions for each GST EAD system and without changing the content of the superloops. For interday variability, ethacrynic acid (6 µM) was injected daily, in triplicate, for 3 days, with fresh solutions in the superloops each day. Intraday and interday variability were found to be less than 3% in the case of the cGSTs EAD system. For the GST P1 EAD system, the intraday and interday variability were found to be less than 4%.
Validation of the cGSTs and GST P1 EAD systems
Microplate reader assays for cGSTs and GST P1 inhibition. The cGSTs and GST P1 EAD systems in the FIA and HPLC modes were validated by comparing IC 50 values of several substrates and inhibitors with those obtained with the corresponding microplate reader assays. For this purpose, 8 test compounds were used-namely, ethacrynic acid, 2-chloro-5-nitrobenzaldehyde, 4chloro-3-dinitrobenzaldehyde, acrolein, and the GSH analogs DB1, DB2, DB3, and DB4 ( Table 1) . All 8 compounds resulted in sigmoidal concentration-response curves. To determine possible differences in their inhibitory properties, the compounds were measured under standard conditions (setup 1) and under GST EAD conditions (setup 2).
GST EAD systems in FIA mode. The performance of both GST EAD systems in FIA mode was evaluated using the same GST ligands and by comparing the results obtained with those of the microplate reader assays. The GST ligands were injected in triplicate in concentrations ranging from 0% to 100% inhibition. A typical result, obtained with ethacrynic acid and the cGSTs EAD system in FIA mode, is shown in Figure 2 .
The total amount of ligand injected was used to calculate the maximum concentration in the reaction coil, in the same way as described by Kool et al. 22 The dilution factor was 9 in the case of cGSTs EAD and 20 in the case of GST P1 EAD. Using these dilution factors, the IC 50 values of the GST ligands were calculated. The results of all 8 test compounds in terms of IC 50 curves are shown in Figure 3 . Table 1 lists all IC 50 values obtained. CDNB, a commonly used substrate for GSTs, 26 was also tested. CDNB, however, gave significant quenching of fluorescence at high concentrations (> 0.5 mM) and hence prevented the construction of accurate IC 50 curves. For ethacrynic acid, detection limits (n = 3; S/N = 3) of 40 nM and 300 nM were obtained with the cGSTs and the GST P1 EAD systems in FIA mode, respectively.
Total HRS GST EAD system. The same 8 ligands as tested in both GST EAD systems in FIA mode were also injected at 5 different concentrations onto the total HRS GST EAD system. The resulting IC 50 values, calculated in a similar way as described above, are also presented in Table 1 . Representative superimposed chromatograms of different concentrations of 1 of the ligands-namely, acrolein-are shown in Figure 4A (cGSTs) and 4B (GST P1). Figure 5A (cGSTs) and 5B (GST P1) shows the corresponding GST EAD traces from a mixture of GST ligands consisting of 4chloro-3-nitrobenzoic acid butyl ester, 2-chloro-5-nitropyridine, acrolein, cinnamaldehyde, crotonaldehyde, and ethacrynic acid.
Using the present total HRS GST EAD system, it should also be possible to screen rapidly and systematically for specific GST P1 inhibitors in compound mixtures. To prove this concept, 4 GST inhibitors, one of which is known to be a specific GST P1 inhibitor, 30, 31 were combined and analyzed with the total HRS GST EAD system. The GST inhibitors, DB1 to DB4, together with their relative affinities as well as the resulting cGSTs and GST P1 EAD traces, are given in Figure 6A and 6B, respectively. Screening of electrophilic compound libraries reacted with GSH. Because many GSH conjugates inhibit GSTs, it can be envisioned that the reaction of GSH or GSH analogs with libraries of electrophilic compounds will result in new libraries of GST inhibitors. 32 Such libraries could be screened with the total HRS GST EAD system for specific GST P1 inhibitors. This hypothesis was tested by reacting GSH at pH 9 with a compound library consisting of α,β-unsaturated carbonyl derivatives, which are all known GST substrates. 33 The resulting compound mixture, consisting of unreacted electrophiles and their corresponding GSH conjugates, was analyzed with the total HRS GST EAD system. Figure 7A shows the UV chromatograms of the library unreacted with GSH (top chromatogram) and reacted with GSH (bottom chromatogram). The corresponding cGSTs and GST P1 EAD traces are shown in Figure 7B and 7C, respectively.
DISCUSSION
We have developed a gradient reversed-phase HPLC-based postcolumn bioaffinity detection system suited for online and simultaneous separation and detection of nonselective cGST inhibitors and selective GST P1 inhibitors in mixtures (HRS GST EAD system) ( Fig. 1) . The concept is based on the inhibition of the enzymatic formation of a fluorescent GSH conjugate. During the optimization of the fluorescence-based GST assay formats, it was shown that for cGSTs, increasing concentrations of organic modifiers decreased the fluorescent signals upon inhibition, probably as a result of enzyme denaturation. On the other hand, for GST P1, increasing organic modifier concentrations initially led to slightly increased fluorescent signals upon inhibition, with maximum signals at 0.5% for all organic modifiers tested. Higher concentrations of the organic modifiers decreased the fluorescent signals upon inhibition, probably due to reduced enzyme activity. Higher concentrations of organic modifier, however, do enable higher concentrations of inhibitory compounds to flow into the GST EAD systems and are essential to achieve good chromatographic separations on standard C18 columns. Higher concentrations of organic modifiers may also have beneficial effects on compound/enzyme adsorption to reaction coil walls. 22 In the present system, organic modifier concentrations of 10% and 4% (v/v) in the reaction coil were found to be acceptable compromises for the cGSTs and GST P1 EAD system, respectively, resulting in about 15% to 20% loss in enzyme activity. These percentages of organic modifier indicate that GSTs are rather stable toward the various organic modifiers compared to other enzymes used in HRS technologies. 22, 34 The IC 50 values obtained with the microplate reader assays under the 2 different experimental conditions (setups 1 and 2) were found to result in similar IC 50 values (Table I) . Therefore, the conditions necessarily to be used in the online GST EAD systems (setup 2; i.e., with PEG6000, Tween 20, and organic modifier) were also expected to give similar results in terms of the GST affinities, as obtained in the microplate reader assay (setup 1; without PEG6000, Tween 20, and organic modifier). The IC 50 values obtained with both GST EAD systems in FIA mode were also in accordance with those obtained with the corresponding microplate reader assays. The IC 50 value of ethacrynic acid was also found to be similar with the literature. 35, 36 The intraday and interday variabilities of both GST EAD systems, both less than 4%, are well within the range of previously reported online bioanalytical screening methods. 23, 37 The IC 50 values finally determined with the total HRS GST EAD system were also found to be in good agreement with those determined with the corresponding microplate reader assays. Apparently, the total HRS GST EAD system can be used for efficient and relatively sensitive online determination of IC 50 values of individual ligands to cGSTs and GST P1 in mixtures ( Fig. 2 and Table 1 ). Compared to other HRS-based systems, similar resolutions in terms of peak widths were obtained. 24, 34 The present total HRS GST EAD system did not show much peak broadening of eluting ligands, as was recently also seen with an HRS EAD system based on cytochrome P450 (i.e., membrane-bound enzymes). 22 This clearly showed the potential of the currently developed total HRS GST EAD system for the determination of affinities of substrates and inhibitors of cGSTs and GST P1. The present total HRS GST EAD system is relatively easy to handle and able to rapidly identify GST inhibitors in mixtures. It allowed for the separation and simultaneous screening for cGSTs and GST P1 affinities of individual GST inhibitors or substrates in mixtures. With the present total HRS GST EAD system, it was also possible to identify specific GST P1 inhibitors among nonselective cGSTs ligands in mixtures, as was demonstrated with a mixture of known GST inhibitors, of which one (DB3) was specific for GST P1 (Fig. 6) . This conclusion, as well as the observed lack of selectivity of DB1, DB2, and DB4 for GST Pi, is in agreement with results found by D. Burg (Leiden, personal communication, 2004) and with the literature. 30, 31, 38, 39 Reaction of mixtures of electrophilic compounds with GSH may result in new libraries or mixtures of GSH conjugates with potentially interesting GST P1-specific inhibitors. This was demonstrated by screening a mixture of a series of α,β-unsaturated carbonyl derivatives reacted with GSH with the present total HRS GST EAD platform. The corresponding cGSTs ( Fig. 7B) and GST P1 EAD (Fig. 7C) traces of the unreacted and the reacted mixtures clearly showed that in the reacted mixture, new, possibly interesting GST inhibitors were formed. It was also shown that the formed GSH conjugate of ethacrynic acid, eluting at 45 min, inhibited cGSTs to about the same extent as ethacrynic acid because both compounds were present in similar concentrations according to the UV trace. This observation was previously also described in literature. 35, 36, 38 The present total HRS GST EAD system can relatively easily and rapidly be applied to screen mixtures or libraries for GST inhibitors, which may contain specific GST P1 inhibitors. It is concluded that the total HRS GST EAD system constitutes a valuable new bioanalytic tool for rapid, simultaneous, and sensitive screening of mixtures for compounds with general cGSTs and/or specific GST P1 binding properties.
CONCLUSIONS
We have developed an HRS platform based on gradient reversed-phase HPLC with a postcolumn online bioaffinity detection system suited for simultaneous detection of individual cGST and GST PI inhibitors in mixtures. The online GST EAD systems in the FIA mode retain the potential to measure IC 50 values, as is the case in traditional microplate reader-based GST assays. The IC 50 values found with the present GST EAD systems were similar to those found with microplate reader assays. This also holds true when the GST EAD systems are coupled online to gradient HPLC. In this case, the resulting HRS GST EAD platform allowed the screening for cGST and GST PI affinity of individual GST ligands or substrates in mixtures. Using this type of parallel screening, it is possible to identify specific GST PI inhibitors in mixtures of general cGST inhibitors. This was demonstrated by HPLC separation and simultaneous postcolumn analysis of a mixture of 4 known GST inhibitors, of which 1 was very specific for GST PI. Reaction of libraries or mixtures of electrophilic compounds with GSH may result in new libraries or mixtures of GSH conjugates with potentially interesting GST PI-specific inhibitors. This concept was demonstrated by reaction of a series of α,β-unsaturated carbonyl derivatives with GSH.
It is concluded that the novel cGST and GST P1 EAD systems in gradient HPLC mode (i.e., in an HRS GST EAD platform) constitute a valuable new bioanalytical tool for rapid and relatively sensitive screening of individual components in complex mixtures of general cGST inhibitors and specific GST PI inhibitors. 
